Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects (2016)
- Authors:
- USP affiliated authors: GUIMARAES, ELAINE APARECIDA DEL BEL BELLUZ - FORP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; ZUARDI, ANTONIO WALDO - FMRP ; GUIMARÃES, FRANCISCO SILVEIRA - FMRP
- Unidades: FORP; FMRP
- DOI: 10.1371/journal.pone.0158779
- Subjects: CANABINOIDES; FLUORAÇÃO; NEUROPSIQUIATRIA; FARMACOLOGIA
- Language: Inglês
- Imprenta:
- Publisher place: San Francisco
- Date published: 2016
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
BREUER, Aviva; HAJ, Christeene G.; FOGAÇA, Manoela V.; et al. Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects. PLOS ONE, San Francisco, v. 11, 2016. Disponível em: < http://dx.doi.org/10.1371/journal.pone.0158779 > DOI: 10.1371/journal.pone.0158779. -
APA
Breuer, A., Haj, C. G., Fogaça, M. V., Gomes, F. V., Silva, N. R., Pedrazzi, J. F., et al. (2016). Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects. PLOS ONE, 11. doi:10.1371/journal.pone.0158779 -
NLM
Breuer A, Haj CG, Fogaça MV, Gomes FV, Silva NR, Pedrazzi JF, Del Bel EA, Hallak JEC, Crippa JA de S, Zuardi AW, Mechoulam R, Guimarães FS. Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects [Internet]. PLOS ONE. 2016 ; 11Available from: http://dx.doi.org/10.1371/journal.pone.0158779 -
Vancouver
Breuer A, Haj CG, Fogaça MV, Gomes FV, Silva NR, Pedrazzi JF, Del Bel EA, Hallak JEC, Crippa JA de S, Zuardi AW, Mechoulam R, Guimarães FS. Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects [Internet]. PLOS ONE. 2016 ; 11Available from: http://dx.doi.org/10.1371/journal.pone.0158779 - Correction: Fluorinated cannabidiol derivatives: enhancement of activity in mice models predictive of anxiolytic, antidepressant and antipsychotic effects
- Possible therapeutic uses of cannabidiol in anxiety disorders and schizophrenia
- Cannabidiol, a cannabis sativa constituent, as an antipsycholic drug
- Canabidiol: possíveis aplicacões terapêuticas em psicopatologias
- Effects of minocycline on regional cerebral blood flow in schizophrenia
- A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation
- Is the highest density of CB1 receptors in paranoid schizophrenia a correlate of endocannabinoid system functioning?
- Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain
- Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implication for neuroprotection
- Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system
Informações sobre o DOI: 10.1371/journal.pone.0158779 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
